Since April 2020, I have been tracking about forty stocks that have been directly and negatively impacted by coronavirus. On that list are airlines, cruise ships, casinos, hotels, and restaurants. TripAdvisor (NASDAQ:TRIP) is also a stock on that list. With Tuesday night's news that Moderna's (MRNA) phase 1 initial trial is going swimmingly, I figure it might be a good time to discuss TripAdvisor. If you are optimistic on a vaccine, and you are looking for a way to bet on life starting to return to normalcy, albeit eventually, you might want to consider shares of TripAdvisor. At the outset of the crisis, TRIP had the advantage of a strong balance sheet, access to credit, and a business model where many variable expenses could be quickly curtailed, thus mitigating some of the major cash burn during the pandemic whereas more capital-intensive industries, like airlines and cruise ships, will burn billions of dollars despite their best efforts.

READ FULL ARTICLE HERE